Cleared Traditional

K233983 - Swan-Ganz Pacing Probe and Catheters (FDA 510(k) Clearance)

Also includes:
Swan-Ganz Bipolar Pacing Catheter (D97120F5) Swan-Ganz Bipolar Pacing Catheter (D97130F5) Swan-Ganz Pacing Thermodilution TD Catheter (D200F7) Chandler Transluminal V-Pacing Probe (D98100)
Jun 2024
Decision
192d
Days
Class 2
Risk

K233983 is an FDA 510(k) clearance for the Swan-Ganz Pacing Probe and Catheters. This device is classified as a Catheter, Flow Directed (Class II - Special Controls, product code DYG).

Submitted by Edwards Lifesciences (Irvine, US). The FDA issued a Cleared decision on June 27, 2024, 192 days after receiving the submission on December 18, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1240.

Submission Details

510(k) Number K233983 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2023
Decision Date June 27, 2024
Days to Decision 192 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DYG - Catheter, Flow Directed
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1240